Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate

NCT00525213 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Rob 803
DRUG: Placebo

Sponsor

OxyPharma